Eli Lilly’s Mounjaro Wins FDA Approval to Cut Cardiovascular Risk in Type 2 Diabetes
The Food and Drug Administration approved Lilly’s Mounjaro on Friday to reduce the risk of cardiovascular death, heart attack, and stroke in adults with type 2 diabetes who are at high risk